Frank Bennett - Concepedia

Author

Frank Bennett

Ionis Pharmaceuticals (United States)

Also Known As

Bennett, F., Bennett, Frank, Bennett, Frank, George, F BENNETT, F Bennett, F. BENNETT, F. Bennett, Frank Bennett

170

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

Ionis Pharmaceuticals (United States)Merck & Co., Inc., Rahway, NJ, USA (United States)University of Nottingham

About

Frank Bennett is an author at Ionis Pharmaceuticals (United States) specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	32	1.4K
2	Natural Sciences	16	21	618
3	Engineering	10	12	234
4	Health Sciences	1	1	17
5	Public Health	1	1	38

Frank Bennett

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
Proteasome Inhibitors Trigger NOXA-Mediated Apoptosis in Melanoma and Myeloma Cells Jian‐Zhong Qin, Jeffrey Ziffra, Lawrence Stennett, Cancer Research	2005	336
Discovery of (1 <i>R</i> ,5 <i>S</i> )- <i>N</i> -[3-Amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]- 3-[2( <i>S</i> )-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2( <i>S</i> )-carboxamide (SCH 503034), a Selective, Potent, Orally Bioavailable Hepatitis C Virus NS3 Protease Inhibitor: A Potential Therapeutic Agent for the Treatment of Hepatitis C Infection Srikanth Venkatraman, Stéphane Bogen, Ashok Arasappan, Journal of Medicinal Chemistry	2006	278
Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mcl-1 Irene M. Pedersen, Shinichi Kitada, Lorenzo M. Leoni, Blood	2002	241
Down-regulation of Survivin by Antisense Oligonucleotides Increases Apoptosis, Inhibits Cytokinesis and Anchorage-Independent Growth Jun Chen, Wei Wu, Stephen K. Tahir, Neoplasia Survivin AssociatesChemoprevention StrategyApoptosisImmunologyInhibits Cytokinesis	2000	211
The triterpenoid CDDO induces apoptosis in refractory CLL B cells Irene M. Pedersen, Shinichi Kitada, Aaron D. Schimmer, Blood	2002	183
Nuclear accumulation of CHMP7 initiates nuclear pore complex injury and subsequent TDP-43 dysfunction in sporadic and familial ALS Alyssa N. Coyne, Victoria Baskerville, Benjamin L. Zaepfel, Science Translational Medicine	2021	134
p53-independent NOXA induction overcomes apoptotic resistance of malignant melanomas Jian‐Zhong Qin, Lawrence Stennett, Patricia Bacon, Molecular Cancer Therapeutics Melanoma Cell LinesP53-independent Noxa InductionMedicineApoptosisMelanoma	2004	128
Discovery of the HCV NS3/4A Protease Inhibitor (1<i>R</i>,5<i>S</i>)-<i>N</i>-[3-Amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3- [2(<i>S</i>)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(<i>S</i>)-carboxamide (Sch 503034) II. Key Steps in Structure-Based Optimization Andrew Prongay, Zhuyan Guo, Nanhua Yao, Journal of Medicinal Chemistry Protein AssemblyMolecular BiologyStructure-based OptimizationChemical BiologyPharmaceutical Chemistry	2007	106
Discovery of Narlaprevir (SCH 900518): A Potent, Second Generation HCV NS3 Serine Protease Inhibitor Ashok Arasappan, Frank Bennett, Stéphane Bogen, ACS Medicinal Chemistry Letters Protease InhibitorsMedicinal ChemistrySynthetic VirologyMedicineSynthetic Sequence	2010	95
Effect of dose and plasma concentration on liver uptake and pharmacologic activity of a 2′-methoxyethyl modified chimeric antisense oligonucleotide targeting PTEN Richard S. Geary, Ed Wancewicz, John Matson, Biochemical Pharmacology Pharmacologic ActivityDrug TargetingBiochemistryMedicinePharmacotherapy	2009	82

Page 1